Health Systems, Inequality and Incentives to Innovate

Rajat Archaryya and Maria Garcia-Alonso

Studies in Economics from School of Economics, University of Kent

Abstract: Governments often subsidize poorer groups in society to ensure their access to new drugs. We analyze here the optimal income-based price subsidies in a strategic environment. We show that asymmetric health systems can arise even though countries are ex-ante symmetric when international price discrimination is possible. Universal access is less likely to arise without price discrimination but also health policy coordination becomes more important. This is due to the multiple equilibria which make the attainment of universal coverage within a given income range ambiguous. We also show that an increase in intra-country inequality does not always lead to less likely universal coverage when international price discrimination is possible.

Keywords: Health systems; Pharmaceuticals; Innovation; Income based subsidies; Price dicsrimination (search for similar items in EconPapers)
JEL-codes: D4 I1 L1 (search for similar items in EconPapers)
Date: 2009-02
New Economics Papers: this item is included in nep-hea and nep-ino
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.kent.ac.uk/economics/repec/0902.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ukc:ukcedp:0902

Ordering information: This working paper can be ordered from

Access Statistics for this paper

More papers in Studies in Economics from School of Economics, University of Kent School of Economics, University of Kent, Canterbury, Kent, CT2 7FS.
Bibliographic data for series maintained by Dr Anirban Mitra ().